Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Eugia Pharma Specialities Limited, is an unlisted public company incorporated on 17 April, 2013. It is classified as a public limited company and is located in Hyderabad, Telangana. It's authorized share capital is INR 800.00 cr and the total paid-up capital is INR 621.01 cr.
Eugia Pharma Specialities Limited's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has increased by 14.54% over the previous year. At the same time, it's book networth has increased by 29.6%.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Read more
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | 142.1 | 402.3 | 1,702.2 | 2,014.4 | 3,150.9 |
Operating profit | 41.2 | 119.6 | 575.4 | 659.0 | 1,405.0 |
Net profit | -24.6 | 0.2 | 367.1 | 267.8 | 800.4 |
Gross margin | 83.3 | 60.5 | 64.5 | 65.7 | 72.7 |
Operating margin | 29.0 | 29.7 | 33.8 | 32.7 | 44.6 |
Net margin | -17.1 | 0.0 | 20.8 | 13.0 | 25.1 |
Networth | 470.6 | 919.1 | 905.7 | 1,173.8 | 1,973.3 |
Borrowings | 477.5 | 311.5 | 890.0 | 1,997.0 | 1,669.8 |
Assets | 1,079.5 | 1,557.6 | 3,189.4 | 4,041.1 | 4,345.5 |
Debt to equity | 1.0 | 0.3 | 1.0 | 1.7 | 0.8 |
Current ratio | 0.8 | 1.3 | 1.1 | 2.3 | 1.6 |
ROE | -5.2 | 0.0 | 40.5 | 22.8 | 40.6 |
Days payable | 547.0 | 262.0 | 186.0 | 180.0 | 194.0 |
WC days | -108.0 | 94.0 | 39.0 | 181.0 | 93.0 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | 477.1 | 621.0 | 621.0 | 621.0 | 621.0 |
Reserves | -6.5 | 298.1 | 284.7 | 552.8 | 1,352.3 |
Borrowings + | 477.5 | 311.5 | 890.0 | 1,997.0 | 1,669.8 |
Long term borrowings | 432.0 | 267.9 | 890.0 | 1,997.0 | 986.3 |
Short term borrowings | 45.5 | 43.6 | - | - | 683.5 |
Trade payables + | 35.6 | 114.0 | 307.6 | 340.8 | 457.0 |
Days payable | 547.0 | 262.0 | 186.0 | 180.0 | 194.0 |
Other liabilities + | 131.3 | 327.1 | 1,393.7 | 870.3 | 702.4 |
Other non-current liabilities | 0.6 | 3.1 | 37.2 | 125.7 | 151.8 |
Other current liabilities | 95.1 | 210.0 | 1,048.9 | 403.8 | 93.6 |
Total liabilities | 1,079.5 | 1,557.6 | 3,189.4 | 4,041.1 | 4,345.5 |
Fixed Assets + | 876.4 | 990.3 | 1,544.1 | 1,808.8 | 1,700.5 |
Tangible assets | 441.3 | 548.3 | 929.7 | 961.6 | 1,052.9 |
CWIP | 417.2 | 376.8 | 524.0 | 481.9 | 363.0 |
Intangible assets | 17.9 | 65.2 | 90.4 | 365.3 | 284.6 |
LT loans and advances | - | - | - | - | - |
Other non-current assets | 68.9 | 96.4 | 106.7 | 490.3 | 611.5 |
Current assets + | 134.2 | 471.0 | 1,538.7 | 1,742.1 | 2,033.5 |
Inventories | 70.1 | 225.9 | 497.9 | 578.2 | 713.5 |
Trade receivables | 8.4 | 162.4 | 411.1 | 675.3 | 799.3 |
Cash and cash equivalents | 24.3 | 0.2 | 112.8 | 120.6 | 47.3 |
ST loans and advances | - | - | 2.1 | 1.7 | 2.0 |
Other current assets | 31.5 | 82.5 | 514.8 | 366.3 | 471.4 |
Total assets | 1,079.5 | 1,557.6 | 3,189.4 | 4,041.1 | 4,345.5 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales + | 142.1 | 402.3 | 1,702.2 | 2,014.4 | 3,150.9 |
Sales growth % | None | 183.02 | 323.14 | 18.34 | 56.42 |
Expenses + | 176.2 | 404.8 | 1,301.3 | 1,695.7 | 2,116.0 |
Cost of goods | 23.8 | 159.0 | 605.2 | 690.9 | 861.9 |
Employee cost | 35.7 | 55.7 | 182.5 | 211.0 | 262.7 |
Other costs | 41.4 | 68.0 | 339.1 | 453.5 | 621.4 |
Operating profit + | 41.2 | 119.6 | 575.4 | 659.0 | 1,405.0 |
Operating margin % | 29.0 | 29.7 | 33.8 | 32.7 | 44.6 |
Other income | 1.2 | 3.6 | 64.9 | 40.0 | 43.3 |
Interest | 41.5 | 39.5 | 40.5 | 129.1 | 141.8 |
Depreciation | 33.7 | 82.7 | 134.0 | 211.3 | 228.3 |
Exceptional items | - | - | - | - | - |
Profit before tax | -32.8 | 1.1 | 465.8 | 358.6 | 1,078.3 |
Tax | -8.3 | 0.9 | 98.7 | 90.8 | 277.8 |
Profit - disc. ops | - | - | - | - | - |
Net profit | -24.6 | 0.2 | 367.1 | 267.8 | 800.4 |
Net margin % | -17.1 | 0.0 | 20.8 | 13.0 | 25.1 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Solvency + | |||||
Total Debt/Equity | 1.0 | 0.3 | 1.0 | 1.7 | 0.8 |
Net Debt/Equity | 1.0 | 0.3 | 0.9 | 1.6 | 0.8 |
Total Debt/Assets | 0.4 | 0.2 | 0.3 | 0.5 | 0.4 |
Total Assets/Equity | 2.3 | 1.7 | 3.5 | 3.4 | 2.2 |
Liquidity + | |||||
Current Ratio | 0.8 | 1.3 | 1.1 | 2.3 | 1.6 |
Quick Ratio | 0.4 | 0.7 | 0.8 | 1.6 | 1.1 |
Interest Coverage | 1.0 | 3.0 | 14.2 | 5.1 | 9.9 |
Performance | |||||
Gross Margin | 83.3 | 60.5 | 64.5 | 65.7 | 72.7 |
Operating Margin | 29.0 | 29.7 | 33.8 | 32.7 | 44.6 |
Net Margin | -17.1 | 0.0 | 20.8 | 13.0 | 25.1 |
Return + | |||||
Return on Equity | -5.2 | 0.0 | 40.5 | 22.8 | 40.6 |
Pre-tax ROCE | 0.9 | 3.4 | 25.6 | 15.9 | 47.1 |
Return on Assets | -2.3 | 0.0 | 11.5 | 6.6 | 18.4 |
Pre-tax ROIC | 0.8 | 3.0 | 26.2 | 14.7 | 32.7 |
Efficiency + | |||||
Days Payable | 547.0 | 262.0 | 186.0 | 180.0 | 194.0 |
Days Inventory | 1,077.0 | 518.0 | 300.0 | 305.0 | 302.0 |
Days Receivable | 22.0 | 147.0 | 88.0 | 122.0 | 93.0 |
Fixed Asset Turnover | 0.2 | 0.4 | 1.1 | 1.1 | 1.9 |
Total Asset Turnover | 0.1 | 0.3 | 0.5 | 0.5 | 0.7 |
Working Capital | |||||
Cash Conversion Cycle | 552.0 | 403.0 | 202.0 | 247.0 | 201.0 |
Working Capital Days | -108.0 | 94.0 | 39.0 | 181.0 | 93.0 |
As per information available, the company has no registered charges.
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Ragunathan Kannan | 00523576 | 3 years |
Director | Madan Mohan Reddy Mettu
Shareholder
|
01284266 | 12 years |
Director | Sundari Raviprasad Pisupati | 01908852 | 3 years |
Director | Santhanam Subramanian | 03516515 | 4 years |
Director | Veerayya Chowdary Kosaraju | 08485334 | 3 years |
CEO | Yugandhar Puvvala | <HIDDEN> | 4 years |
Director | Yugandhar Puvvala | 09379957 | 3 years |
CS | Venkat Reddy Kupireddy | <HIDDEN> | 6 years |
Kmp | Vallamkondu Aravind Kumar | <HIDDEN> | 1 years |
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
TRUST AMC TRUSTEE PRIVATE LIMITED |
Active
|
50.0 L | 1 | Maharashtra |
NU GENES AGRI BUSINESS PRIVATE LIMITED |
Active
|
1.8 L | 1 | Telangana |
SATHGURU MANAGEMENT CONSULTANTS PVT LTD |
Active
|
30.0 L | 1 | Telangana |
FERNANDEZ FOUNDATION |
Active
|
24.0 L | 1 | Telangana |
SATHGURU SOFTWARE PRODUCTS PRIVATE LIMITED |
Active
|
6.8 Cr | 1 | Telangana |
PREMIER ENERGIES LIMITED |
Active
|
45.1 Cr | 1 | Telangana |
AUROBINDO PHARMA LTD |
Active
|
58.1 Cr | 1 | Telangana |
OREMSI PLASTICS PRIVATE LIMITED |
Strike Off
|
1.3 L | 1 | Telangana |
CUREPRO PARENTERALS LIMITED |
Amalgamated
|
13.3 Cr | 2 | Telangana |
AURONEXT PHARMA PRIVATE LIMITED |
Amalgamated
|
125.0 Cr | 1 | Telangana |
THERANYM BIOLOGICS PRIVATE LIMITED |
Active
|
10.0 L | 2 | Telangana |
AUROZEST PRIVATE LIMITED |
Active
|
10.0 L | 1 | Telangana |
AURO VACCINES PRIVATE LIMITED |
Active
|
10.0 L | 1 | Telangana |
CREST EXCIPIENTS LLP |
Strike Off
|
1.3 L | 1 | Telangana |
EUGIA STERILES PRIVATE LIMITED |
Active
|
44.2 Cr | 2 | Telangana |
CURATEQ BIOLOGICS PRIVATE LIMITED |
Active
|
100.0 Cr | 1 | Telangana |
PRAVESHA INDUSTRIES PRIVATE LIMITED |
Active
|
10.0 Cr | 1 | Telangana |
EUGIA SEZ PRIVATE LIMITED |
Active
|
4.0 Cr | 4 | Telangana |
RAINBOW SPECIALITY HOSPITALS PRIVATE LIMITED |
Active
|
18.0 Cr | 1 | Telangana |
RAINBOW CHILDREN'S MEDICARE LIMITED |
Active
|
101.6 Cr | 1 | Telangana |
QULE PHARMA PRIVATE LIMITED |
Active
|
10.0 L | 1 | Andhra Pradesh |
AUROACTIVE PHARMA PRIVATE LIMITED |
Active
|
100.0 Cr | 1 | Telangana |
TERGENE BIOTECH LIMITED |
Active
|
45.0 Cr | 1 | Telangana |
APITORIA PHARMA PRIVATE LIMITED |
Active
|
99.0 Cr | 1 | Telangana |
LYFIUS PHARMA PRIVATE LIMITED |
Active
|
10.0 L | 1 | Andhra Pradesh |
ANANT RAJ LIMITED |
Active
|
68.4 Cr | 1 | Haryana |
GENOME FOUNDATION |
Active
|
81.5 L | 1 | Telangana |
GMR VARALAKSHMI FOUNDATION |
Active
|
0.0 | 1 | Andhra Pradesh |
DIVI'S LABORATORIES LIMITED |
Active
|
53.0 Cr | 1 | Telangana |
MY HOME INDUSTRIES PRIVATE LIMITED |
Active
|
51.0 Cr | 1 | Telangana |
CCL PRODUCTS (INDIA) LIMITED |
Active
|
26.7 Cr | 1 | Andhra Pradesh |
NUZIVEEDU SEEDS LIMITED |
Active
|
86.3 Cr | 1 | Telangana |
RELIANCE INDUSTRIES LIMITED |
Active
|
6,766.2 Cr | 1 | Maharashtra |
TATA MOTORS LIMITED |
Active
|
736.2 Cr | 1 | Maharashtra |
RELIANCE JIO INFOCOMM LIMITED |
Active
|
45,000.0 Cr | 1 | Gujarat |
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
EUGIA SEZ PRIVATE LIMITED | Telangana | 2021 | ₹ 4.0 Cr |
EUGIA INJECTABLE INC.,USA | United States | - | - |
EUGIA STERILES PRIVATE LIMITED | Telangana | 2020 | ₹ 44.2 Cr |
Eugia Pharma B.V | Netherlands | - | - |
Eugia pharma (malta) limited | Malta | - | - |
Eugia (uk) limited | United Kingdom | - | - |
Eugia Pharma Inc Canada | Canada | - | - |
Eugia Pharma (Austalia) PTY Limited | Australia | - | - |
Eugia pharma industria farmaceutica limitada | Brazil | - | - |
Eugia Inc | United States | - | - |
Eugia pharma colombia SAS | Colombia | - | - |
The incorporation date of EUGIA PHARMA SPECIALITIES LIMITED is 17 April, 2013
The authorized share capital of EUGIA PHARMA SPECIALITIES LIMITED is INR ₹ 800.0 Cr.
The paid-up capital of EUGIA PHARMA SPECIALITIES LIMITED is INR ₹ 621.0 Cr.
The registered address of EUGIA PHARMA SPECIALITIES LIMITED is Plot No.2, Maitrivihar, NA Ameerpet Hyderabad Telangana - 500038
The CIN number of EUGIA PHARMA SPECIALITIES LIMITED is U24297TG2013PLC087048.